Myomo surges on Q2 revenue beat
** Robotic medical device maker's MYO.A shares rise as
much as 20.38% to $9.45 premarket
** Co reports Q2 revenue of $3.1 million, beating Refinitiv
estimates of $2.1 mln, helped by higher orders for its MyoPro
product line urn:newsml:reuters.com:*:nBw1FzDFba
** MYO expects to deliver solid year-over-year revenue
growth in the third quarter - CEO
** Stock up ~16% YTD, as of last close
(Reporting by Rithika Krishna in Bengaluru)
((Rithika.Krishna@thomsonreuters.com;))